Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitivia is an Italian specialty pharmaceutical company focused on the development and commercialization of advanced dermatological and cosmeceutical products. The company is best known for its proprietary Singledose technology, a patented delivery system that uses biodegradable, gelatin-based capsules to protect pure, unstable active ingredients like vitamins from oxidation and degradation. Vitivia's product portfolio includes high-concentration topical formulations of Vitamin A (Retinol), Vitamin C (L-Ascorbic Acid), and Vitamin E (Tocopherol), which are used to treat photoaging, acne, and various skin conditions. The company's technology allows for the delivery of these potent ingredients without the need for preservatives or fragrances, minimizing the risk of skin irritation. Vitivia's products are distributed globally through partnerships with major pharmaceutical companies such as Meda (now Viatris).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitivia.